نتائج البحث - "Victor Sarradin"

المساهمون: Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université Fédérale Toulouse Midi-Pyrénées, Fournié, jean-jacques, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Toulouse [Toulouse], CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: JCI Insight
JCI Insight, 2021, 6 (2), ⟨10.1172/jci.insight.142513⟩
JCI Insight, Vol 6, Iss 2 (2021)
JCI Insight, American Society for Clinical Investigation, 2021, 6 (2), ⟨10.1172/jci.insight.142513⟩

مصطلحات موضوعية: Male, 0301 basic medicine, Lymphocyte, [SDV]Life Sciences [q-bio], Lymphocyte Cooperation, Programmed Cell Death 1 Receptor, Immunology, T cells, Gene Expression, Uterine Cervical Neoplasms, Cancer immunotherapy, CD8-Positive T-Lymphocytes, In Vitro Techniques, Biology, Lymphocyte Activation, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Antigens, Neoplasm, Immune Tolerance, medicine, Humans, Cytotoxic T cell, RNA, Messenger, CD154, Ovarian Neoplasms, Immunity, Cellular, Apyrase, T-Lymphocytes, Helper-Inducer, General Medicine, Dendritic cell, Immune checkpoint, Tumor antigen, [SDV] Life Sciences [q-bio], 030104 developmental biology, medicine.anatomical_structure, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Cancer research, Medicine, Female, Tumor Escape, Cytokine secretion, CD8, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4d843042bee75d1bda7779727348c6Test
https://hal.science/hal-03365487Test

10

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study

المؤلفون: Amélie Lusque, Camille Franchet, Victor Sarradin, Thomas Filleron, Florence Dalenc

المصدر: Breast Cancer Research : BCR
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)

مصطلحات موضوعية: Oncology, medicine.medical_treatment, Triple Negative Breast Neoplasms, B7-H1 Antigen, Tumor-infiltrating lymphocytes, 0302 clinical medicine, Surgical oncology, Tumor Microenvironment, Hepatitis A Virus Cellular Receptor 2, RC254-282, Triple-negative breast cancer, 0303 health sciences, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Prognosis, Lymphocyte Activation Gene 3 Protein, Neoadjuvant Therapy, Treatment Outcome, 030220 oncology & carcinogenesis, Immunohistochemistry, Female, Immune checkpoint, Research Article, Adult, PD-L1, medicine.medical_specialty, TIM-3, Neoadjuvant chemotherapy, 03 medical and health sciences, Young Adult, Breast cancer, Lymphocytes, Tumor-Infiltrating, Antigens, CD, LAG-3, Internal medicine, medicine, Biomarkers, Tumor, Humans, TILs, 030304 developmental biology, Aged, Retrospective Studies, Chemotherapy, business.industry, medicine.disease, Survival Analysis, Immune microenvironment, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e577c8b94b938415758ee82e7c4ee2Test
https://pubmed.ncbi.nlm.nih.gov/34039396Test

تنقيح النتائج